Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

CVS Health (CVS) Plans To Boost Hourly Minimum Wage Rate

Published 02/12/2018, 10:00 PM
Updated 07/09/2023, 06:31 AM

CVS Health Corporation (NYSE:CVS) recently announced three major programs that will allow the company to share the tax benefit earned from the implementation of the latest U.S. Tax Cuts and Jobs Act with employees. This news comes on the heels of the company’s promising fourth-quarter 2017 results. Along with the results, the company exhibited unwavering commitment toward employees’ welfare.

According to management, the improvement in employee wages and benefits totaled $425 million annually. These are long-term and compensation investments, expected to create growth opportunities for the company and its employees.

The programs include the following three employee-focused investments:

First, CVS Health will lift the starting wage rate to $11 an hour for hourly employees, effective April 2018. With a view to grow its retail stores into a healthcare destination, the company plans to adjust pay ranges and rates for many of its retail pharmacy technicians, front store associates and other hourly retail employees later this year.

Second, the company wishes to consistently offer affordable healthcare services to workers by not increasing employee premiums for 2018-19, despite a 5% year-over-year rise in medical and prescription costs. CVS Health will absorb the entire increase for the 100,000 employees who are part of the company-sponsored health plan.

Finally, a new paid parental leave plan will be put into effect starting April 1, 2018, for full-time employees. Per management, an employee who welcomes a new child can take up to four weeks away from work at 100% of their pay, so as to ensure proper care of the newborn.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Additionally, management indicated that it will put the remaining benefits earned from tax savings back into the business. The company expects to channelize this money toward data analytics, care management solutions and store service, in order to improve health outcomes, reduce cost for patients and also debt reduction related to the planned acquisition of Aetna (NYSE:AET).

Recent Accolades

Recently, CVS Health has been recognized as one of the World’s Most Admired Companies by Fortune Magazine. The company was honored as No. 39 on corporate rankings, up six spots from the previous year in terms of corporate performance and reputation and ability to attract and retain talented people, quality of services, management, innovation and social responsibility.

Price Performance

Over the last six months, CVS Health has outperformed the industry. The stock has lost 11.9%, lower than the industry’s decline of 13.6%.

Zacks Rank & Stocks to Consider

CVS Health carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader medical space are Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) , HCA Healthcare, Inc. (NYSE:HCA) and athenahealth Inc. (NASDAQ:ATHN) . Each of these stocks sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Amphastar has an impressive expected long-term growth rate of 25%. In the last six months, the stock has rallied 25.3%.

HCA Healthcare has a projected long-term growth rate of 11.5%. In the last three months, the stock has gained 29.2%.

athenahealth has a long-term growth rate of 23.1%. Over the last three months, the stock has rallied 6.8%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>



athenahealth, Inc. (ATHN): Free Stock Analysis Report

Amphastar Pharmaceuticals, Inc. (AMPH): Free Stock Analysis Report

HCA Holdings, Inc. (HCA): Free Stock Analysis Report

CVS Health Corporation (CVS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.